Fresenius Kabi makes a significant investment!
Fresenius Kabi is investing approximately € 100 million into the Emmer-Compascuum site
Today, Fresenius Kabi announced that it will be investing considerably in its site in Emmer-Compascuum. Fresenius Kabi is a large multinational that makes very many medical products for and provides services to healthcare. The company produces products for blood separation techniques in Emmer-Compascuum. The announced investment will ensure that the Emmer-Compascuum site will be suitable for a different activity: clinical nutrition production. Production is scheduled to start in 2020.
Production of medical nutrition is an existing activity of Fresenius Kabi. Due to increased demand, the company must ramp up production. The company has deemed the Emmer-Compascuum site as being suitable for this.
Putting down roots in the region
Alderman Bouke Arends: ‘It’s great that Fresenius Kabi is investing considerably in Emmer-Compascuum. This clarifies the situation about the future of the company in our region. Fresenius Kabi is giving a clear signal with this investment. We are glad that Fresenius Kabi has decided to expand its economic activities in Emmer-Compascuum. The number of jobs that this investment will safeguard is also an important issue.’
Prospects for the future
Member of the Provincial Executive Henk Brink: ‘Together with the municipality of Emmen, we have, as the province, held talks with Fresenius Kabi on a regular basis about the developments during the last few years at the site in Emmer-Compascuum. We are very happy with this result. This investment creates opportunities for the future. The excellent partnership with, for example, the Investment and Development Agency for the Northern Netherlands (NOM), the Netherlands Foreign Investment Agency (NFIA) and, in particular, the Dutch Ministry of Economic Affairs and Climate has in part contributed to keep Fresenius Kabi in the region.”